SYNTELLO VACCINE DEV KB has a total of 28 patent applications. Its first patent ever was published in 1991. It filed its patents most often in Australia, Canada and United States. Its main competitors in its focus markets pharmaceuticals, biotechnology and medical technology are HELIX RES INST, PAUL SUDHIR and TYKOCINSKI MARK L.
# | Country | Total Patents | |
---|---|---|---|
#1 | Australia | 7 | |
#2 | Canada | 4 | |
#3 | United States | 4 | |
#4 | Finland | 2 | |
#5 | Hungary | 2 | |
#6 | Monaco | 2 | |
#7 | Norway | 2 | |
#8 | African Intellectual Property Organization | 2 | |
#9 | WIPO (World Intellectual Property Organization) | 2 | |
#10 | Republic of Korea | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Medical technology | |
#4 | Machines |
# | Technology | |
---|---|---|
#1 | Peptides | |
#2 | Medical preparations | |
#3 | Therapeutic chemical compounds | |
#4 | Microorganisms | |
#5 | Object sterilising | |
#6 | Unspecified technologies |
# | Name | Total Patents |
---|---|---|
#1 | Horal Peter | 28 |
#2 | Jeansson Stig | 28 |
#3 | Rymo Lars | 27 |
#4 | Vahlne Anders | 26 |
#5 | Svennerholm Bo | 25 |
#6 | Czerkinsky Cecil | 5 |
#7 | Holmgren Jan | 5 |
#8 | Svennerholm Bo Rymo Lars | 1 |
#9 | Vahle Anders | 1 |
#10 | Syennerholm Bo | 1 |
Publication | Filing date | Title |
---|---|---|
AU7423896A | Peptides for use in induction of T cell activation against HIV-1 | |
US5627035A | Peptides that block human immunodeficiency virus and methods of use thereof | |
US5840313A | Peptides for use in vaccination and induction of neutralizing antibodies against human immunodeficiency virus | |
WO9423746A1 | Peptides for use in vaccination and induction of neutralizing antibodies against human immunodeficiency virus | |
US5346989A | Peptides for use in induction of T cell activation against HIV-1 | |
HU9300877D0 | Method for producing proteines applicables by injection and inducing anti-bodies having neutralizing effect against virus of human immun insufficiency | |
AU8433291A | Peptides that block human immunodeficiency virus infections and methods of use thereof |